FDA panel overrules own scientists to ease access to unproven peptide injections

The FDA's Pharmacy Compounding Advisory Committee voted 8-6 to recommend unproven peptides BPC-157, KPV, TB-500, and MOTS-c for compounding pharmacy access, overruling the agency's own scientists.

• FDA Panel Clears the Way for 6 Banned Peptides. Here’s What They’re Claimed to Do
• RFK Jr.'s hand-picked committee approves manufacture of peptides he uses
• FDA panel overrules its own scientists to ease access to unproven peptide injections
• An FDA Panel Just Endorsed These Unproven Peptides
• The Great Peptide Cash Grab Has Begun